ReviewEukaryotic cell2007
Biosynthesis and immunogenicity of glucosylceramide in Cryptococcus neoformans and other human pathogens.
Review in Eukaryotic cell, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 38 citations in OpenAlex.
- Glycosphingolipids in Filamentous Fungi: Biological Roles and Potential Applications in Cosmetics and Health Foods.Frontiers in microbiology · 2021Review
- Immunization Strategies for the Control of Histoplasmosis.Current tropical medicine reports · 2019Article
- Membrane Sphingolipids Regulate the Fitness and Antifungal Protein Susceptibility ofFrontiers in microbiology · 2019Article
- Review
- A Predicted Mannoprotein Participates inmSphere · 2018Article
- Current trends to control fungal pathogens: exploiting our knowledge in the host-pathogen interaction.Infection and drug resistance · 2018Review
- Plasma membrane lipids and their role in fungal virulence.Progress in lipid research · 2016Review
- Transmembrane transporter expression regulated by the glucosylceramide pathway in Cryptococcus neoformans.BMC research notes · 2015Article
- Sterylglucoside catabolism in Cryptococcus neoformans with endoglycoceramidase-related protein 2 (EGCrP2), the first steryl-β-glucosidase identified in fungi.The Journal of biological chemistry · 2015Article
- Challenges posed by extracellular vesicles from eukaryotic microbes.Current opinion in microbiology · 2014Review
- Structural diversity and biological significance of glycosphingolipids in pathogenic and opportunistic fungi.Frontiers in cellular and infection microbiology · 2014Review
- Synthesis and biological properties of fungal glucosylceramide.PLoS pathogens · 2014Review
- Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans.Cellular microbiology · 2012Article
- Quality control of fungus-specific glucosylceramide in Cryptococcus neoformans by endoglycoceramidase-related protein 1 (EGCrP1).The Journal of biological chemistry · 2012Article
- A xylosylphosphotransferase of Cryptococcus neoformans acts in protein O-glycan synthesis.The Journal of biological chemistry · 2011Article
- Lipid signalling in pathogenic fungi.Cellular microbiology · 2011Review
- Surface localization of glucosylceramide during Cryptococcus neoformans infection allows targeting as a potential antifungal.PloS one · 2011Article
- Sphingolipid signaling in fungal pathogens.Advances in experimental medicine and biology · 2010Review
- Sphingolipid C-9 methyltransferases are important for growth and virulence but not for sensitivity to antifungal plant defensins in Fusarium graminearum.Eukaryotic cell · 2009Article
- How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.Annual review of microbiology · 2009Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 3 countries.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.